These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19186291)

  • 21. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [SEPAR: work published in 2008].
    Ancochea J; Casan P
    Arch Bronconeumol; 2009; 45 Suppl 1():1-2. PubMed ID: 19303522
    [No Abstract]   [Full Text] [Related]  

  • 23. Nurses and the pharmaceutical industry: part 2.
    Olsen DP
    Am J Nurs; 2009 Feb; 109(2):86-7. PubMed ID: 19300016
    [No Abstract]   [Full Text] [Related]  

  • 24. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The five vital pressure points between pharmaceutical manufacturers and the public.
    BECKWITH ER
    GP; 1959 Jun; 19(6):151-4. PubMed ID: 13653272
    [No Abstract]   [Full Text] [Related]  

  • 26. Only one handed applause due.
    Griffith D
    BMJ; 2013 Apr; 346():f1954. PubMed ID: 23550072
    [No Abstract]   [Full Text] [Related]  

  • 27. The decline of pharmaceutical psychiatry and the increasing role of psychological medicine.
    Fava GA
    Psychother Psychosom; 2009; 78(4):220-7. PubMed ID: 19401622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.
    Zhang Z; Jia M; Wan D
    Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical representatives do influence physician behaviour.
    Harris G
    Fam Pract; 2009 Jun; 26(3):169-70. PubMed ID: 19482948
    [No Abstract]   [Full Text] [Related]  

  • 30. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Merck offers money back guarantee on finasteride.
    Tonks A
    BMJ; 1994 Nov; 309(6964):1252-3. PubMed ID: 7888840
    [No Abstract]   [Full Text] [Related]  

  • 32. [Respiratory medicine and the new A/H1N1 flu: from a Mexican point of view].
    Pérez-Padilla R; Torre-Bouscoulet L
    Arch Bronconeumol; 2009 Jul; 45(7):313-4. PubMed ID: 19556050
    [No Abstract]   [Full Text] [Related]  

  • 33. Public perceptions of health care professionals' participation in pharmaceutical marketing.
    Crigger NJ; Courter L; Hayes K; Shepherd K
    Nurs Ethics; 2009 Sep; 16(5):647-58. PubMed ID: 19671650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Who's winning the human race?"Cold war as pharmaceutical political strategy.
    Tobbell DA
    J Hist Med Allied Sci; 2009 Oct; 64(4):429-73. PubMed ID: 19493917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time for the medical profession to act: new policies needed now on interactions between pharmaceutical companies and physicians.
    Greenland P
    Arch Intern Med; 2009 May; 169(9):829-31. PubMed ID: 19433693
    [No Abstract]   [Full Text] [Related]  

  • 36. [Respiratory Medicine in 2001].
    Rev Mal Respir; 2002 Jun; 19 Spec No():3S9-183. PubMed ID: 12185999
    [No Abstract]   [Full Text] [Related]  

  • 37. [Palliative care in respiratory medicine].
    Magnussen H; Heigener DF; Bausewein C; Thomas M; Eschbach C; Schütte W; Blankenburg T; Steins M; Bischoff H; Schucher B; Rosseau S; Schütz A; Geiseler J; Kampf S; Karg O
    Pneumologie; 2009 May; 63(5):289-95. PubMed ID: 19418389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 39. The AUA as a barometer of the health of the pharmaceutical industry.
    Wyllie MG
    BJU Int; 2009 Jun; 103(11):1581-2. PubMed ID: 19489792
    [No Abstract]   [Full Text] [Related]  

  • 40. Key opinion leaders: How to spot one.
    Spiers AS
    BMJ; 2008 Jul; 337(7662):a790. PubMed ID: 18632709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.